Salivary immunoglobulins in recipients of bone marrow grafts III. A longitudinal follow-up of CMV specific antibodies

Bone Marrow Transplantation

Volumn 17, Issue 2, 1996, Pages 237-241

  Chaushu, G ^a,b   Chaushu, S ^a,b   Slavin, S ^c   Or, R ^c   Garfunkel, A A ^b   Yefenof, E ^a,d  

^a Lautenberg Ctr Gen Tum Immunol   (Israel)

^b Oral Medicine Service

^c HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^d NONE   (Israel)

Author keywords

Bone marrow transplantation; CMV; MALT; Salivary immunoglobulins

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYTARABINE; CYTOMEGALOVIRUS ANTIBODY; IMMUNOGLOBULIN; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; MELPHALAN; METHOTREXATE;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; ANTIBODY DETECTION; ANTIBODY PRODUCTION; APLASTIC ANEMIA; ARTICLE; B LYMPHOCYTE; BONE MARROW TRANSPLANTATION; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HODGKIN DISEASE; HUMAN; MALE; MYELOPROLIFERATIVE DISORDER; NONHODGKIN LYMPHOMA; PLASMA CELL; PRIORITY JOURNAL; SALIVA ANALYSIS; SCHOOL CHILD;

EID: 0030064512     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Neiman PE, Reeves W. Ray G, et al. A prospective analysis of interstitial pneumonia and opportunistic viral infection among recipients of allogeneic bone marrow grafts. J Infect Dis 1977; 136: 754-767.
2. Engelhard D, Or R, Strauss N et al. Cytomegalovirus infection and disease after T cell-depleted allogeneic bone marrow transplantation (BMT) for malignant hematological diseases. Transplant Proc 1989; 21: 3101-3102.
3. Meyers JD. Flournoy N. Thomas ED. Risk factors for cytomegalovirus infection after human marrow transplantation. J Infect Dis 1986; 153: 478-488.
4. Meyers JD, Flurnoy N, Thomas ED. Nonbacterial pneumonia after allogeneic marrow transplantation: a review of ten years' experience. Rev Infect Dis 1982; 4: 1119-1132.
5. Hersman J, Meyers JD, Thomas ED. The effect of granulocyte transfusions on the incidence of cytomegalovirus infection after allogenic marrow transplantation. Ann Intern Med 1982; 96: 149-152.
6. Waldmann H, Polliak A, Hale G et al. Elimination of graftversus-host disease by in vitro depletion of alloreactive lymphocytes with a monoclonal rat anti-human lymphocyte antibody (CAMPATH-1). Lancet 1984; 2: 483-485.
7. Quinnan GV Jr, Kirmani N. Rook AH et al. Cytotoxic T cells in cytomegalovirus infection: HLA-restricted T-lymphocyte and non-T-lymphocyte cytotoxic responses correlate with recovery from cytomegalovirus in bone marrow transplant recipients. New Engl J Med 1982; 307: 6-13.
8. Simmons RS. Matas AJ, Rattazzi LC, Clinical characteristics of the lethal cytomegalovirus infection following renal transplantation. Surgery 1977; 82: 537-546.
9. Yeager AS, Gmmet FC, Hafleigh EB. Prevention of transfusion-acquired cytomegalovirus infections in newborn infants. J Pediatr 1981; 98: 281-287.
10. Hurlimann J, Lichaa M. Local immunization in the mammary glands of the rabbit. J Immunol 1976; 116: 1295-1301.
11. Waldman RH, Ganguly R. Immunity to infections on secretory surfaces. J Infect Dis 1974; 130: 419-440.
12. Brandtzaeg P, Fjellanger I, Gjerulden ST. Human secretory immunoglobulins. I. Salivary secretions from individuals with normal or low levels of serum immunoglobulins. Scand J Haematol 1970; 12 (suppl): 1-83.
13. Wells JV. Immunoglobulins: biosynthesis and metabolism. In: Fudenberg HH, Stites DP, Caldwell JL, Wells JV (eds). Basic and Clinical Immunology. Lange Med Publ: Los Altos, CA, 1980, pp 72-73.
14. Chaushu S, Chaushu G, Garfunkel AA et al. Salivary immunoglobulins in recipients of bone marrow grafts. I. A longitudinal follow-up. Bone Marrow Transplant 1994; 14: 871-876.
15. Thomas ED. Buckner CD, Banaji M et al. One hundred patients with acute leukemia treated by chemotherapy, total body irradiation, and allogeneic marrow transplantation. Blood 1977, 49: 511-533.
16. Copelan EA, Deeg HJ. Conditioning for allogeneic marrow transplantation in patients with lymphohematopoietic malignancies without the use of total body irradiation. Blood 1992; 80: 1648-1658.
17. Slavin S, Naparstek E, Aker M et al. The use of total lymphoid irradiation (TLI) for prevention of rejection of T-lymphocyte depleted bone marrow allografts in non-malignant hematological disorders. Transplant Proc 1989; 21: 3053-3054.
18. Slavin S, Waldrnann H, Or R et al. Prevention of graft-vs-host disease in allogeneic bone marrow transplantation. Transplant Proc 1985; 17: 465-467.
19. Waldrnann H, Polliak A, Hale G et al. Elimination of graftversus-host disease by in vitro depletion of alloreactive lymphocytes with a monoclonal rat anti-human lymphocyte antibody (CAMPATH-1). Lancet 1984; 2: 483-485.
20. Baum BJ. Evaluation of stimulated parotid saliva flow rate in different age groups. J Dent Res 1981; 60: 1292-1296.
21. Baum BJ, Kousvelari EE, Oppenheim FG. Exocrine protein secretion from human parotid glands during aging. stable release of the acidic proline rich proteins. J Geront 1982; 37: 392-395.
22. Parry JV, Perry KR, Mortimer PP. Sensitive assays for viral antibodies in saliva: an alternative to tests on serum. Lancet 1987; 11: 72-75.
23. Thieme T, Placentini S, Davidson S. Steingart K. Determination of measles, mumps and rubella immunization status using oral fluid samples. JAMA 1994; 272: 219-221.
24. Mestecky J, McGhee JR, Arnold RR et al. Selective induction of an immune response in human external secretions by ingestion of bacterial antigen. J Clin Invest 1978; 61: 731-737.
25. Tamura T, Chiba S, Chiba Y, Nakao T. Virus excretion and neutralizing antibody response in saliva in human cytomegalo-virus infection. Infect Immunol 1980; 29; 842-845.
26. Chaushu S, Chaushu G, Garfunkel AA et al. Salivary immunoglobulins in recipients of bone marrow grafts. II. Transient secretion of donor derived salivary IgA following T cell-depleted transplantation. Bone Marrow Transplant 1994; 14: 925-928.
27. Bass EB, Powe NR, Goodman SN et al. Efficacy of immune globulin in preventing complications of bone marrow transplantation: a meta-analysis. Bone Marrow Transplant 1993; 12: 273-282.
28. Snydman DR, Werner BG, Heinze-Lacey B et al. Use of cytomegalovirus immune globulin to prevent cytomegalovirus disease in renal-transplant recipients. New Engl J Med 1987; 317: 1049-1054.